PGEN
PRECIGEN, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.78
−1.14%Forward multiples
Based on analyst estimates
- P/E forward
- 16.04x
- P/E 2026E
- 55.91x
- P/E 2027E
- 11.45x
- P/E 2028E
- 12.73x
- P/S forward
- 8.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 63.92x
- Price / sales
- 32.50x
- Price / cash flow
- -24.40x
Enterprise value
- Enterprise value
- $2.8B
- EV / sales
- 33.20x
- EV / EBITDA
- -19.63x
- EV / EBIT
- -72.04x
- Market cap
- $2.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026